Consolidated Statement Of Stockholder's Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated other comprehensive (loss) income	Retained Earnings (Accumulated Deficit)	Noncontrolling Interest in subsidiaries (deficiency)
Balance, shares at Dec. 31, 2021		65,517
Balance, amount at Dec. 31, 2021	$ 76,941	$ 0	$ 116,810	$ (1,108)	$ (38,536)	$ (225)
Common shares issued for business combinations, shares		9,500
Common shares issued for business combinations, amount	14,697	$ 0	14,697	0	0	0
Common shares issued for other agreements, shares		111
Common shares issued for other agreements, amount	272	$ 0	272	0	0	0
Acquisition of noncontrolling interest, shares		131
Acquisition of noncontrolling interest, amount	(54)	$ 0	283	0	(365)	28
Options issued	1,443	$ 0	1,443	0	0	0
Options exercised, shares		333
Options exercised, amount	50	$ 0	50	0	0	0
Warrants exercised, shares		51
Warrants exercised, amount	28	$ 0	28	0	0	0
Share issuance costs	(79)	0	(79)	0	0	0
Other comprehensive loss- exchange differences on foreign operations (net of income taxes of $nil)	(577)	0	0	(577)	0	0
Net Income (Loss)	(7,630)	$ 0	0	0	(7,566)	(64)
Balance, shares at Mar. 31, 2022		75,643
Balance, amount at Mar. 31, 2022	85,091	$ 0	133,504	(1,685)	(46,467)	(261)
Balance, shares at Dec. 31, 2022		135,573
Balance, amount at Dec. 31, 2022	56,412	$ 0	150,420	(2,732)	(90,865)	(411)
Options issued	119	0	119	0	0	0
Other comprehensive loss- exchange differences on foreign operations (net of income taxes of $nil)	357	0	0	357	0	0
Net Income (Loss)	(3,905)	$ 0	0	0	(3,876)	(29)
Equity issued for other agreements, shares		325
Equity issued for other agreements, amount	95	$ 0	95	0	0	0
Options cancelled	0	$ 0	(765)	0	765	0
Restricted units granted, shares		1,040
Restricted units granted, amount	534	$ 0	534	0	0	0
Balance, shares at Mar. 31, 2023		136,938
Balance, amount at Mar. 31, 2023	$ 53,612	$ 0	$ 150,403	$ (2,375)	$ (93,976)	$ (440)